Perivascular Epithelioid Cell Neoplasms
"Perivascular Epithelioid Cell Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A family of mesenchymal tumors composed of histologically and immunohistochemically distinctive perivascular epithelioid cells. These cells do not have a normal anatomic homolog. (From Fletcher CDM, et. al., World Health Organization Classification of Tumors: Pathology and Genetics of Tumors of Soft Tissue and Bone, 2002).
| Descriptor ID |
D054973
|
| MeSH Number(s) |
C04.557.450.692
|
| Concept/Terms |
Clear-Cell Sugar Tumors- Clear-Cell Sugar Tumors
- Clear Cell Sugar Tumors
- Clear-Cell Sugar Tumor
- Sugar Tumor, Clear-Cell
- Sugar Tumors, Clear-Cell
- Tumor, Clear-Cell Sugar
- Tumors, Clear-Cell Sugar
Clear-Cell Myomelanocytic Tumors- Clear-Cell Myomelanocytic Tumors
- Clear Cell Myomelanocytic Tumors
- Clear-Cell Myomelanocytic Tumor
- Myomelanocytic Tumor, Clear-Cell
- Myomelanocytic Tumors, Clear-Cell
- Tumor, Clear-Cell Myomelanocytic
- Tumors, Clear-Cell Myomelanocytic
- CCMMT
|
Below are MeSH descriptors whose meaning is more general than "Perivascular Epithelioid Cell Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Perivascular Epithelioid Cell Neoplasms".
This graph shows the total number of publications written about "Perivascular Epithelioid Cell Neoplasms" by people in this website by year, and whether "Perivascular Epithelioid Cell Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Perivascular Epithelioid Cell Neoplasms" by people in Profiles.
-
Sustained response to pembrolizumab in recurrent perivascular epithelioid cell tumor with elevated expression of programmed death ligand: a case report. J Med Case Rep. 2021 Jul 24; 15(1):400.